Anxiety Disorders Protocol

Mental HealthStrong Evidence

supplements

Primary

Supporting

Grade A

Studies

Primary Stack

Core supplements with strongest evidence

KavaA

300mg daily (standardized to kavalactones)

Binds to GABA-A receptors and modulates limbic system activity, producing anxiolytic effects without cognitive impairment

↑Anxiety Symptoms↑Aggression↑Subjective Well-Being↑Depression Symptoms↑Liver Enzymes

7 studies380 participants

Supporting Studies (2)

PMID: 12807341 - Kava-kava extract WS 1490 versus placebo in anxiety disorders (2003)PMID: 23635869 - Kava for the treatment of generalised anxiety disorder (2013)

AshwagandhaB

600mg daily

Modulates the HPA axis by reducing cortisol levels and enhancing GABAergic signaling through withanolide compounds

↑Anxiety Symptoms↑Stress Signs and Symptoms↑Sleep Duration↑Sleep Efficiency↑Sleep Latency

10 studies540 participants

Supporting Studies (2)

PMID: 23439798 - A prospective study on safety and efficacy of Ashwagandha root in stress and anxiety (2012)PMID: 32021735 - Efficacy and safety of ashwagandha root extract in insomnia and anxiety (2020)

Supporting Stack

Additional supplements for enhanced results

LavenderB

80mg daily (Silexan)

Inhibits voltage-gated calcium channels and modulates NMDA receptor activity, reducing neuronal hyperexcitability

↑Anxiety Symptoms↑Blood Pressure↑Heart Rate↑Cortisol↑Sleep Quality

19 studies1,893 participants

Supporting Studies (2)

PMID: 20512042 - Silexan, an orally administered Lavandula oil preparation, for anxiety disorder (2010)PMID: 24456909 - Lavender oil preparation Silexan is effective in generalized anxiety disorder (2014)

SaffronB

30mg daily

Increases serotonin reuptake inhibition via crocin and safranal compounds while providing antioxidant neuroprotection

↑Anxiety Symptoms↑Depression Symptoms↑Sleep Quality

3 studies180 participants

Supporting Studies (1)

PMID: 27701683 - Crocus sativus L. (saffron) for anxiety and depression: a meta-analysis (2016)

How This Protocol Works

Simple Explanation

Anxiety disorders involve an overactive stress response system in the brain. When you experience anxiety, your brain's alarm centers (particularly the amygdala) become hyperactive, while calming signals from GABA receptors are weakened. This creates a cycle of worry, tension, and physical symptoms like rapid heartbeat and restlessness.

•Kava works directly on GABA receptors, the brain's primary calming system. It produces relaxation similar to anti-anxiety medications but without causing drowsiness or mental fog. Studies show moderate improvement in anxiety symptoms.

•Ashwagandha targets the stress hormone cortisol by calming the hypothalamic-pituitary-adrenal (HPA) axis. Lower cortisol means your body stays out of fight-or-flight mode more easily. It also supports GABA activity.

•Lavender (as Silexan capsules) calms overexcited nerve cells by blocking calcium channels that trigger neuronal firing. This gentle effect helps reduce the physical and mental symptoms of anxiety.

•Saffron supports healthy serotonin levels, the neurotransmitter associated with mood and emotional balance. It also protects brain cells from oxidative stress.

Expected timeline: Initial calming effects from kava within days. Ashwagandha and saffron show benefits at 4-6 weeks. Optimal results at 8-12 weeks of consistent use.

Clinical Perspective

The pathophysiology of anxiety disorders involves dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, altered GABAergic neurotransmission, and hyperactivation of the amygdala-mediated fear circuitry. This protocol targets multiple molecular nodes within these pathways.

•Kava (A-grade): Kavalactones bind to GABA-A receptor subunits, potentiating inhibitory chloride ion conductance. Modulates limbic system structures including amygdala and hippocampus. Inhibits voltage-gated sodium and calcium channels, reducing neuronal excitability. 7 RCTs with 380 participants show moderate improvement in HAM-A scores (PMID: 12807341).

•Ashwagandha (B-grade): Withanolides suppress cortisol secretion by modulating CRH and ACTH release. Enhances GABA receptor binding and GAD enzyme activity. Reduces inflammatory cytokines (IL-6, TNF-α) associated with anxiety. 10 studies demonstrate significant reductions in DASS, PSS, and Hamilton anxiety scales (PMID: 23439798).

•Lavender/Silexan (B-grade): Inhibits N-type and P/Q-type voltage-gated calcium channels. Reduces glutamatergic excitatory transmission. Modulates serotonin 5-HT1A receptor binding. 19 studies with 1,893 participants show efficacy comparable to low-dose benzodiazepines (PMID: 20512042).

•Saffron (B-grade): Crocin and safranal inhibit serotonin reuptake transporters (SERT). Provides BDNF-enhancing effects supporting neuroplasticity (PMID: 27701683).

Biomarker targets: Salivary cortisol, GABA levels (where measurable), inflammatory markers (hs-CRP, IL-6).

Protocol notes: Monitor for sedation and avoid alcohol. Kava requires liver function monitoring with use >3 months.

View All Protocols